Bromocriptine mesylate
NDC 68382-110, Bromocriptine mesylate, capsule, from Zydus Pharmaceuticals USA Inc..
- Product NDC
- 68382-110
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078899
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68382-110 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BROMOCRIPTINE MESYLATE5 mg/1
Pharmacologic classes
Ergolines [CS]; Ergot Derivative [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68382-110-01 | 68382011001 | 100 CAPSULE in 1 BOTTLE (68382-110-01) |
| 68382-110-06 | 68382011006 | 30 CAPSULE in 1 BOTTLE (68382-110-06) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d69003ee-0b6f-47a9-834e-ba59c02f566cNADAC price for package 68382011006
GET /v1/drugs/nadac/68382011006
Use it
Look up 68382-110 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68382-110 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68382-110. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.